AstraZeneca vaccine furore exposing 'frailties' of EU

A link between AstraZeneca’s Covid-19 vaccine and a rare type of blood clot has been acknowledged by European drug regulators.
When European drug regulators acknowledged a link between AstraZeneca’s Covid-19 vaccine and a rare type of blood clot, it spread another dose of scepticism across the continent.
But in the poorer east, the doubts are more over the findings than the shot.